A detailed history of Laurion Capital Management LP transactions in Argenx Se stock. As of the latest transaction made, Laurion Capital Management LP holds 5,000 shares of ARGX stock, worth $2.76 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,000
Holding current value
$2.76 Million
% of portfolio
0.03%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$356.01 - $451.55 $1.78 Million - $2.26 Million
5,000 New
5,000 $2.15 Million
Q3 2020

Nov 13, 2020

SELL
$215.51 - $272.51 $603,428 - $763,028
-2,800 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$127.44 - $232.72 $356,832 - $651,616
2,800 New
2,800 $631,000
Q1 2020

May 14, 2020

SELL
$108.83 - $165.23 $185,011 - $280,891
-1,700 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$106.59 - $164.21 $467,610 - $720,389
-4,387 Reduced 72.07%
1,700 $273,000
Q3 2019

Nov 13, 2019

SELL
$113.31 - $150.51 $71,385 - $94,821
-630 Reduced 9.38%
6,087 $694,000
Q2 2019

Aug 13, 2019

BUY
$115.0 - $141.58 $490,475 - $603,838
4,265 Added 173.94%
6,717 $951,000
Q1 2019

May 08, 2019

BUY
$98.85 - $134.59 $242,380 - $330,014
2,452 New
2,452 $306,000
Q4 2018

Feb 14, 2019

SELL
$63.81 - $109.82 $9 Million - $15.5 Million
-141,000 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$75.5 - $96.63 $10.6 Million - $13.6 Million
141,000 New
141,000 $10.7 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $30.5B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.